Keywords: approval, novartis, generic, betaferon, eu, swiss, drug

Approval for Novartis' generic Betaferon in EU

Article | 02 June 2008

Swiss drug major Novartis has received approval from the European Commission for Extavia (interferon beta-1b), its generic version of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in